1-[3-[2-[2-[[3,5-Dihydroxy-6-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)morpholin-4-yl]propylamino]-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-2,3,4,5-tetrol

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 1-[3-[2-[2-[[3,5-Dihydroxy-6-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)morpholin-4-yl]propylamino]-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-2,3,4,5-tetrol
• 英文别名: 1-[3-[2-[2-[[3,5-dihydroxy-6-methyl-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-6-(hydroxymethyl)morpholin-4-yl]propylamino]-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyhexane-2,3,4,5-tetrol
• 化学式: C₃₉H₇₂N₂O₂₇
• 分子量: 1001.0
• InChiKey: LRCQLBRFTZPAEX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -10.5
• 重原子数：
  68
• 可旋转键数：
  23
• 环数：
  5.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  463
• 氢给体数：
  19
• 氢受体数：
  29

文献信息

• MODIFIED AND DERIVATIZED ß-GLUCAN COMPOUNDS, COMPOSITIONS, AND METHODS
  申请人：Biothera, Inc.

  公开号：US20140228543A1

  公开（公告）日：2014-08-14

  Modified and/or derivativized β-glucans with an enhanced capacity to modulate human immune response as compared to the parent, unmodified and/or underivatized β-glucans are demonstrated.

  改性和/或衍生的β-葡聚糖表现出比未改性和/或未衍生的β-葡聚糖更强的调节人类免疫反应的能力。